Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot Study
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
UNLABELLED: Metabolic syndrome is associated with disturbances in gut microbiota composition. We aimed to investigate the effect of Lactobacillus casei Shirota (LcS) on gut microbiota composition, gut barrier integrity, intestinal inflammation and serum bile acid profile in metabolic syndrome. In a single-centre, prospective, randomised controlled pilot study, 28 subjects with metabolic syndrome received either LcS for 12 weeks (n = 13) or no LcS (n = 15). Data were compared to healthy controls (n = 16). Gut microbiota composition was characterised from stool using 454 pyrosequencing of 16S rRNA genes. Serum bile acids were quantified by tandem mass spectrometry. Zonulin and calprotectin were measured in serum and stool by ELISA. Bacteroidetes/Firmicutes ratio was significantly higher in healthy controls compared to metabolic syndrome but was not influenced by LcS. LcS supplementation led to enrichment of Parabacteroides. Zonulin and calprotectin were increased in metabolic syndrome stool samples but not influenced by LcS supplementation. Serum bile acids were similar to controls and not influenced by LcS supplementation. Metabolic syndrome is associated with a higher Bacteroidetes/Firmicutes ratio and gut barrier dysfunction but LcS was not able to change this. LcS administration was associated with subtle microbiota changes at genus level. TRIAL REGISTRATION: ClinicalTrials.gov NCT01182844.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952 · cited 1×
“[11, 12] This suggests that the microbiota might be involved in the pathogenesis of obesity, insulin resistance and T2DM, possibly by having an impact on gut barrier integrity and inflammation.”
Microbiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457
Human gut microbiota in obesity and after gastric bypass
Zhang, H., DiBaise, J. K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., Parameswaran, P., Crowell, M. D., Wing, R., Rittmann, B. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812600106 · Cited by 1,880
The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age
Mariat, D., Firmesse, O., Levenez, F., Guimarăes, V., Sokol, H., Doré, J., Corthier, G., & Furet, J.-P. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-123 · Cited by 1,755 · cited 1×
“[69] This study suggests that investigating gut microbiota composition is challenging and interventions are difficult.”
Ironing out the wrinkles in the rare biosphere through improved OTU clustering
Huse, S. M., Welch, D. M., Morrison, H. G., & Sogin, M. L. (2010) · Environmental Microbiology · doi:10.1111/j.1462-2920.2010.02193.x · Cited by 1,346
Human colonic microbiota associated with diet, obesity and weight loss
Duncan, S. H., Lobley, G. E., Holtrop, G., Ince, J., Johnstone, A. M., Louis, P., & Flint, H. J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.155 · Cited by 1,222
Creely, S. J., McTernan, P. G., Kusminski, C. M., Fisher, F. M., Da Silva, N. F., Khanolkar, M., Evans, M., Harte, A. L., & Kumar, S. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00302.2006 · Cited by 1,043 · cited 1×
“[11, 12] This suggests that the microbiota might be involved in the pathogenesis of obesity, insulin resistance and T2DM, possibly by having an impact on gut barrier integrity and inflammation.”
The role of the gut microbiota in energy metabolism and metabolic disease
Cani, P., & Delzenne, N. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168164 · Cited by 974 · cited 1×
“[15, 16] Despite several mechanistic studies and encouraging results in animals [17, 18] interventional data on probiotics use in humans with MetS are rare.”
Gut microbiome, obesity, and metabolic dysfunction
Tilg, H., & Kaser, A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58109 · Cited by 860
Research works printed but not linked: 48
- GN Thomas, 2007, Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor Study, Clinical endocrinology, 66, 666, 10.1111/j.1365-2265.2007.02798.x · DOI · Paper page
- RE Ley, 2005, Obesity alters gut microbial ecology, Proc Natl Acad Sci U S A, 102, 11070, 10.1073/pnas.0504978102 · DOI · Paper page
- F Backhed, 2005, Host-bacterial mutualism in the human intestine, Science, 307, 1915, 10.1126/science.1104816 · DOI · Paper page
- ML Zupancic, 2012, Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome, PLoS One, 7, e43052, 10.1371/journal.pone.0043052 · DOI · Paper page
- PD Cani, 2008, Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice, Diabetes, 57, 1470, 10.2337/db07-1403 · DOI · Paper page
- E Naito, 2011, Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice, J Appl Microbiol, 110, 650, 10.1111/j.1365-2672.2010.04922.x · DOI · Paper page
- AS Andreasen, 2010, Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects, Br J Nutr, 104, 1831, 10.1017/S0007114510002874 · DOI · Paper page
- B Leber, 2012, The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study, Eur J Clin Nutr, 66, 1110, 10.1038/ejcn.2012.103 · DOI
- NJ Tripolt, 2012, Short communication: Effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, beta-cell function, and markers of endothelial function and inflammation in subjects with metabolic syndrome-A pilot study, J Dairy Sci
- KG Alberti, 2009, Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity, Circulation, 120, 1640, 10.1161/CIRCULATIONAHA.109.192644 · DOI · Paper page
- GC Baker, 2003, Review and re-analysis of domain-specific 16S primers, J Microbiol Methods, 55, 541, 10.1016/j.mimet.2003.08.009 · DOI · Paper page
- K Watanabe, 2001, Design and evaluation of PCR primers to amplify bacterial 16S ribosomal DNA fragments used for community fingerprinting, J Microbiol Methods, 44, 253, 10.1016/S0167-7012(01)00220-2 · DOI · Paper page
- T Stojakovic, 2007, Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid, Hepatology, 46, 776, 10.1002/hep.21741 · DOI · Paper page
- JG Caporaso, 2010, QIIME allows analysis of high-throughput community sequencing data, Nature methods, 7, 335, 10.1038/nmeth.f.303 · DOI · Paper page
- RC Edgar, 2010, Search and clustering orders of magnitude faster than BLAST, Bioinformatics, 26, 2460, 10.1093/bioinformatics/btq461 · DOI · Paper page
- Q Wang, 2007, Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy, Appl Environ Microbiol, 73, 5261, 10.1128/AEM.00062-07 · DOI · Paper page
- D McDonald, 2012, An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea, ISME J, 6, 610, 10.1038/ismej.2011.139 · DOI · Paper page
- JG Caporaso, 2010, PyNAST: a flexible tool for aligning sequences to a template alignment, Bioinformatics, 26, 266, 10.1093/bioinformatics/btp636 · DOI · Paper page
- BJ Haas, 2011, Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons, Genome research, 21, 494, 10.1101/gr.112730.110 · DOI · Paper page
- MN Price, 2010, FastTree 2—approximately maximum-likelihood trees for large alignments, PLoS One, 5, e9490, 10.1371/journal.pone.0009490 · DOI · Paper page
- F Backhed, 2007, Mechanisms underlying the resistance to diet-induced obesity in germ-free mice, Proc Natl Acad Sci U S A, 104, 979, 10.1073/pnas.0605374104 · DOI · Paper page
- RE Ley, 2010, Obesity and the human microbiome, Current opinion in gastroenterology, 26, 5, 10.1097/MOG.0b013e328333d751 · DOI · Paper page
- V Tremaroli, 2012, Functional interactions between the gut microbiota and host metabolism, Nature, 489, 242, 10.1038/nature11552 · DOI · Paper page
- PJ Parekh, 2014, The Role and Influence of Gut Microbiota in Pathogenesis and Management of Obesity and Metabolic Syndrome, Front Endocrinol (Lausanne), 5, 47, 10.3389/fendo.2014.00047 · DOI · Paper page
- J Qin, 2012, A metagenome-wide association study of gut microbiota in type 2 diabetes, Nature, 490, 55, 10.1038/nature11450 · DOI · Paper page
- S Fukuda, 2014, Gut microbiome and metabolic diseases, Seminars in immunopathology, 36, 103, 10.1007/s00281-013-0399-z · DOI
- RE Ley, 2005, Obesity alters gut microbial ecology, Proc Natl Acad Sci U S A, 102, 11070, 10.1073/pnas.0504978102 · DOI · Paper page
- P De Cruz, 2014, Specific Mucosa-Associated Microbiota in Crohn's Disease at the Time of Resection are Associated with Early Disease Recurrence: A Pilot Study, Journal of gastroenterology and hepatology
- VW Wong, 2013, Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis—a longitudinal study, PLoS One, 8, e62885, 10.1371/journal.pone.0062885 · DOI · Paper page
- M Shirota, 1966, Studies on intestinal microflora. 1. Its constitution in healthy infants and the effect of oral administration of L. acidophilus strain Shirota, Nippon saikingaku zasshiJapanese journal of bacteriology, 21, 274
- S Spanhaak, 1998, The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans, Eur J Clin Nutr, 52, 899, 10.1038/sj.ejcn.1600663 · DOI · Paper page
- KM Tuohy, 2007, Survivability of a probiotic Lactobacillus casei in the gastrointestinal tract of healthy human volunteers and its impact on the faecal microflora, J Appl Microbiol, 102, 1026
- K Takeda, 2007, Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity, The Journal of nutrition, 137, 791S, 10.1093/jn/137.3.791S · DOI · Paper page
- V Stadlbauer, 2008, Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis, J Hepatol, 48, 945, 10.1016/j.jhep.2008.02.015 · DOI · Paper page
- S Tiengrim, 2012, Viability of Lactobacillus casei strain Shirota (LcS) from feces of Thai healthy subjects regularly taking milk product containing LcS, Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 95, S42
- N Yuki, 1999, Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: selective isolation from faeces and identification using monoclonal antibodies, International journal of food microbiology, 48, 51, 10.1016/S0168-1605(99)00029-X · DOI · Paper page
- J Fujimoto, 2008, Identification and quantification of Lactobacillus casei strain Shirota in human feces with strain-specific primers derived from randomly amplified polymorphic DNA, International journal of food microbiology, 126, 210, 10.1016/j.ijfoodmicro.2008.05.022 · DOI
- T Sakai, 2010, M-RTLV agar, a novel selective medium to distinguish Lactobacillus casei and Lactobacillus paracasei from Lactobacillus rhamnosus, International journal of food microbiology, 139, 154, 10.1016/j.ijfoodmicro.2010.03.019 · DOI
- L Tilley, 2014, A probiotic fermented milk drink containing Lactobacillus cassei strain Shirota improves stool consistency of subjects with hard stools, International Journal of Probiotics and Prebiotics, 9, 23
- A Fasano, 2000, Regulation of intercellular tight junctions by zonula occludens toxin and its eukaryotic analogue zonulin, Ann N Y Acad Sci, 915, 214, 10.1111/j.1749-6632.2000.tb05244.x · DOI · Paper page
- A Fasano, 2000, Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease, Lancet, 355, 1518, 10.1016/S0140-6736(00)02169-3 · DOI · Paper page
- JM Moreno-Navarrete, 2012, Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance, PLoS One, 7, e37160, 10.1371/journal.pone.0037160 · DOI · Paper page
- KM Goodrich, 2012, Chronic administration of dietary grape seed extract increases colonic expression of gut tight junction protein occludin and reduces fecal calprotectin: a secondary analysis of healthy Wistar Furth rats, Nutr Res, 32, 787, 10.1016/j.nutres.2012.09.004 · DOI
- LK Stenman, 2013, Genetically obese mice do not show increased gut permeability or faecal bile acid hydrophobicity, Br J Nutr, 110, 1157, 10.1017/S000711451300024X · DOI
- B Liaset, 2011, Nutritional regulation of bile acid metabolism is associated with improved pathological characteristics of the metabolic syndrome, The Journal of biological chemistry, 286, 28382, 10.1074/jbc.M111.234732 · DOI · Paper page
- M Watanabe, 2011, Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure, The Journal of biological chemistry, 286, 26913, 10.1074/jbc.M111.248203 · DOI · Paper page
- C Steiner, 2011, Bile acid metabolites in serum: intraindividual variation and associations with coronary heart disease, metabolic syndrome and diabetes mellitus, PLoS One, 6, e25006, 10.1371/journal.pone.0025006 · DOI · Paper page
- N Voreades, 2014, Diet and the development of the human intestinal microbiome, Frontiers in microbiology, 5, 494, 10.3389/fmicb.2014.00494 · DOI · Paper page
Cited by
Probiotics and prebiotics in intestinal health and disease: from biology to the clinic
Sanders, M. E., Merenstein, D. J., Reid, G., Gibson, G. R., & Rastall, R. A. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0173-3 · Cited by 2,059
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., & Assi, H. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020786 · Cited by 1,441
The pros, cons, and many unknowns of probiotics
Suez, J., Zmora, N., Segal, E., & Elinav, E. (2019) · Nature Medicine · doi:10.1038/s41591-019-0439-x · Cited by 1,398
Chávez-Talavera, O., Tailleux, A., Lefebvre, P., & Staels, B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.055 · Cited by 970
Cuevas-Sierra, A., Ramos-Lopez, O., Riezu-Boj, J. I., Milagro, F. I., & Martinez, J. A. (2019) · Advances in Nutrition · doi:10.1093/advances/nmy078 · Cited by 523
Metadata
- Authors
- Stadlbauer, V., Leber, B., Lemesch, S., Trajanoski, S., Bashir, M., Horvath, A., Tawdrous, M., Stojakovic, T., Fauler, G., Fickert, P., Högenauer, C., Klymiuk, I., Stiegler, P., Lamprecht, M., Pieber, T. R., Tripolt, N. J., & Sourij, H.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-10-28
- Volume
- 10
- Issue
- 10
- Pages
- e0141399
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1861469615
- Cited by
- 59
- References
- 20
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot Study. https://app.cochat.ai/papers/10.1371/journal.pone.0141399
- The paper
- Stadlbauer, V., Leber, B., Lemesch, S., Trajanoski, S., Bashir, M., Horvath, A., Tawdrous, M., Stojakovic, T., Fauler, G., Fickert, P., Högenauer, C., Klymiuk, I., Stiegler, P., Lamprecht, M., Pieber, T. R., Tripolt, N. J., & Sourij, H. (2015). Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot Study. PLOS ONE. https://doi.org/10.1371/journal.pone.0141399
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.